Discriminative stimulus properties of (±)-fenfluramine: The role of 5-HT2 receptor subtypes

Behavioral Neuroscience

Volumn 117, Issue 2, 2003, Pages 212-221

  McCreary, Andrew C ^a,c   Filip, Malgorzata ^b   Cunningham, Kathryn A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; FENFLURAMINE; KETANSERIN; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG POTENTIATION; MALE; NONHUMAN; RAT; REINFORCEMENT;

ANIMALS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; FENFLURAMINE; FLUOROBENZENES; INDOLES; KETANSERIN; MALE; PIPERIDINES; PYRAZINES; PYRIDINES; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; REINFORCEMENT (PSYCHOLOGY); SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPIRO COMPOUNDS; SULFONAMIDES; THIOPHENES;

EID: 0344643437     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.117.2.212     Document Type: Article

References (46)

1. 2 agonists in rats. Pharmacology and Toxicology, 64, 165-172.
2. Barnes, N. M., & Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology, 38, 1083-1152.
3. 2B) in rat stomach fundus longitudinal muscle. British Journal of Pharmacology, 112, 323-331.
4. 1B receptor cell line. European Journal of Pharmacology, 360, 117-121.
5. 2C receptor antagonist. Neuropharmacology, 36, 621-629.
6. Bourson, A., Wanner, D., Wyler, R., Petit, N., Zwingelstein, C., Rudler, A., & Sleight, A. J. (1996). Pharmacological evaluation of the discriminative stimulus properties of metachlorophenylpiperazine. Pharmacology Biochemistry and Behavior, 53, 107-114.
7. 2C in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). European Journal of Pharmacology, 257, 27-38.
8. Cunningham, K. A., & Appel, J. B. (1987). Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). Psychopharmacology, 91, 67-73.
9. Cunningham, K. A., Callahan, P. M., & Appel, J. B. (1986). Discriminative stimulus properties of the serotonin agonist MK 212. Psychopharmacology, 90, 193-197.
10. 1D autoreceptors. British Journal of Pharmacology, 114, 1107-1109
11. 2C receptor agonist, RO 60-0175: A pharmacological analysis. Neuropharmacology, 38, 415-423.
12. Duxon, M. S., Flanigan, T. P., Reveley, A. C., Baxter, G. S., Blackurn, T. P., & Fone, K. C. (1997). Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience, 76, 323-329.
13. 1A receptors in the discriminative stimulus effects of fenfluramine. Acta Neurobiologica Experimentalis, 5, 234.
14. 2B receptors in the cardiopathy associated with fenfluramine. Molecular Pharmacology, 57, 75-81.
15. Fuxe, K., Farnebo, L. O., Hamberger, B., & Ogren, S. O. (1975). On the "in vivo" and "in vitro" actions of fenfluramine and its derivatives on central monoaminergic neurons, especially 5-hydroxytryptamine neurons and their relations to the anorectic actions of fenfluramine. Journal of Postgraduate Medicine, 51(Suppl 1), 35-45.
16. Garattini, S., Buczko, W., Jori, A., & Samanin R. (1975). On the mechanism of actions of fenfluramine. Journal of Postgraduate Medicine, 51(Suppl), 27-34.
17. Glowinski, L. (1970). Effects of amphetamine on various aspects of catecholamine metabolism in the central nervous system of the rat. In E. Costa & S. Garattini (Eds.), Amphetamine and related compounds (pp. 301-316). New York: Raven Press.
18. 2C receptor mode of action. Psychopharmacology, 137, 292-302.
19. Gotesman, K. G., & Gunne, L. M. (1972). Subjective effects of two anorexigenic agents, fenfluramine and AN448, on amphetamine dependent subjects. British Journal of Addiction, 67, 39-44.
20. Goudie, A. J. (1977). Discriminative stimulus properties of fenfluramine in an operant task: An analysis of its cue function. Psychopharmacology, 53, 97-102.
21. Hopwood, S. E., & Stamford, J. A. (2001). Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei. Neuropharmacology, 40, 508-519.
22. 1 recognition sites. Journal of Receptor Research, 8, 59-81.
23. Hoyer, D., Clark, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994). International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacology Review, 46, 157-203.
24. 1D beta receptors. Circulation, 90, 1141-1153.
25. 2A antagonist with a favorable CNS safety profile. Journal of Pharmacology and Experimental Therapeutics, 277, 968-981.
26. 1C receptors and their therapeutic relevance. Current Opinions in Investigational Drugs, 2, 317-362.
27. 2B receptor agonist, BW 723C86, on three rat models of anxiety. British Journal of Pharmacology, 117, 1443-1448.
28. 2B receptor antagonist with anxiolytic-like properties. British Journal of Pharmacology, 117, 427-434.
29. 2A/2C antagonist anxiolytics: II. Drug discrimination and behavioral observation studies in rats. Journal of Pharmacology and Experimental Therapeutics, 282, 747-759.
30. 2C receptor agonists: Pharmacological characteristics and therapeutic potential. Journal of Pharmacology and Experimental Therapeutics, 286, 913-924.
31. McElroy, J. F., & Feldman, R. S. (1984). Discriminative stimulus properties of fenfluramine: Evidence for serotonergic involvement. Psychopharmacology, 83, 172-178.
32. McTavish, D., & Heel, R. C. (1992). Dexfenfluramine: A review of its pharmacological properties and therapeutic potential in obesity. Drugs, 43, 713-733.
33. 2C receptors mediated penile erections in rats: Actions of novel and selective agonists and antagonists. European Journal of Pharmacology, 325, 9-12.
34. Moret, C., & Briley, M. (1997). 5-HT autoreceptors in the regulation of 5-HT release from guinea pig raphe nucleus and hypothalamus. Neuropharmacology, 36, 1713-1723.
35. 1D receptors in the rat brain. Synapse, 22, 54-62.
36. 2C receptors in CHO-K1 cells. British Journal of Pharmacology, 128, 13-20.
37. 2C receptor. Journal of Pharmacology and Experimental Therapeutics, 299, 83-89.
38. Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000). Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation, 102, 2836-2841.
39. Schechter, M. D. (1997). Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats. Life Sciences, 60, 83-90.
40. Schechter, M. D., & Rosecrans, J. A. (1973). d-Amphetamine as a discriminative stimulus cue: Drugs with similar stimulus properties. European Journal of Pharmacology, 21, 212-216.
41. Schreiber, R., Brocco, M., & Millan, M. J. (1994). Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. European Journal of Pharmacology, 264, 99-102.
42. Weissman, A., Koe, B. K., & Tenen, S. S. (1966). Anti-amphetamine effects of inhibition of tyrosine hydroxylase. Journal of Pharmacology and Experimental Therapeutics, 151, 339-352.
43. White, F. J., & Appel, J. B. (1979). Discriminative stimulus properties of quipazine: Direct serotonergic mediation. Neuropharmacology, 18, 143-151.
44. White, F. J., & Appel, J. B. (1981). A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology, 73, 110-115.
45. Winter, J. C. (1980). Effects of phenyethylamine derivatives, BL 3912, fenfluramine and SCH 12679 in rats trained with LSD as a discriminative stimulus. Psychopharmacology, 68, 159-162.
46. 1D receptor subfamily. Journal of Neurochemistry, 68, 410-418.